Can These Dividend Stocks Beat the Market Again in 2026?

• Building connected a beardown 2025, CVS Health's outlook for 2026 and beyond looks promising.

• Amgen is processing newer cause products that volition code a caller patent cliff.

• Both stocks are beardown options for dividend seekers to adhd to their portfolios.

• 10 stocks we similar amended than CVS Health ›

Last twelvemonth was a rebound 1 for CVS Health (NYSE: CVS) and Amgen (NASDAQ: AMGN). After underperforming broader equities successful 2024, some healthcare giants bounced backmost successful 2025, outperforming the marketplace handily, contempt the remainder of the assemblage not being arsenic fortunate. Are determination bully reasons to deliberation CVS Health and Amgen could erstwhile again apical the marketplace this year?

Let's analyse intimately however 2026 could unfold for some and find whether they are worthy superior information for semipermanent investors.

CVS Health's fiscal results weren't exceptional successful 2025, but aft a mates of years of adjacent worse ones, the marketplace began to spot wide signs of improvement. And that looks apt to proceed successful 2026, arsenic CVS Health precocious updated its guidance for the year, raising projections for revenue, operating income, and net per stock compared to its erstwhile guidance.

Meanwhile, the pharmacy concatenation is addressing immoderate of the challenges it has faced successful caller years, including rising costs and shrinking operating margins, particularly successful its Medicare Advantage (MA) business. This year, the institution plans to importantly rotation backmost its MA concern and absorption connected profitable growth.

That volition yet pb to stronger margins. So, 2026 looks promising for the company, and 1 much crushed to deliberation it could execute good this twelvemonth is that the banal appears reasonably valued. CVS Health is trading astatine 11.2 times guardant earnings, compared to an mean of 18.4 for the healthcare sector.

But what astir beyond 2026? That's what's much important. And careless of however CVS Health performs this year, the institution appears to beryllium a beardown semipermanent investment. It has a immense web of pharmacies crossed the U.S., immoderate of which person been portion of their communities for decades. CVS Health besides has diversified healthcare operations, which see its security concern and immoderate superior attraction services, allowing it to support patients wrong its ecosystem.

All these are monolithic advantages that it tin leverage arsenic healthcare spending increases. Although it has faced contention from companies similar Amazon, CVS Health has dilatory adapted, notably by offering escaped and accelerated transportation services for medicine medications. CVS Health whitethorn oregon whitethorn not outperform the S&P 500 this year, but the banal is simply a beardown prime for semipermanent investors, particularly erstwhile considering the dividend.